Skip to main content
Premium Trial:

Request an Annual Quote

NIH Awards Phase I SBIR to NanoInk for DNA Array Development

NEW YORK, Nov. 18 (GenomeWeb News) - NanoInk has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to support the development of its Dip Pen Nanolithography technology for miniaturizing DNA arrays, the company said today.

NanoInk said the grant is the first award of a two-phase $1.3 million award. Phase I SBIR's are generally in the $100,000 range.

The company said the grant is a result of an NIH initiative to facilitate multidisciplinary work in nanotechnology. The DPN process is able to precisely position molecules on a surface, which permits direct-deposition printing of features with nanometer-scale dimensions, according to NanoInk.

The company said it can use the technique to create biomolecule nanoarrays with features that are up to 10,000 times smaller than those produced with conventional microarray technology.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.